PLEASE CITE Nature GENETICS AS THE SOURCE OF THE FOLLOWING ITEM. IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO THE JOURNAL’S WEBSITE, http://www.nature.com/naturegenetics
New genetic risk factor for type 2 diabetes
DOI: 10.1038/ng2043
Variation in the gene called CDKAL1 is associated with risk of developing type 2 diabetes, according to a study to be published online this week in Nature Genetics.
Valgerdur Steinthorsdottir and colleagues discovered this new risk variant through a large-scale survey in Iceland in which they compared the frequencies of several hundred thousand common genetic variants in healthy individuals with those who have the disease. They subsequently replicated the association between type 2 diabetes and a variant in CDKAL1 in samples from several independent populations of European or Han Chinese ancestry. Individuals with two copies of the risk variant were found to be at increased risk for developing disease compared to individuals with only a single copy of the risk variant. Such individuals also had approximately 20% less insulin response than individuals with only one copy or non-carriers, suggesting that the variant may confer risk of type 2 diabetes through reduced insulin secretion.
Author contacts:
Edward Farmer (Director of Corporate Communication, deCODE genetics Inc)
Tel: +1 646 417 4555; E-mail: [email protected]
Valgerdur Steinthorsdottir (deCODE Genetics, Reykjavik, Iceland)
E-mail: [email protected]
Kari Stefansson (deCODE Genetics, Reykjavik, Iceland)
E-mail: [email protected]
PRESS CONTACTS…
For North America and Canada
Katie McGoldrick (Nature Washington)
Tel: +1 202 737 2355; E-mail: [email protected]
For Japan, Korea, China, Singapore and Taiwan
Mika Nakano (Nature Tokyo)
Tel: +81 3 3267 8751; E-mail: [email protected]
For the UK/Europe/other countries not listed above
Katherine Anderson (Nature, London)
Tel: +44 20 7843 4502; E-mail: [email protected]
Ruth Francis (Senior Press Officer, Nature, London)
Tel: +44 20 7843 4562; E-mail: [email protected]
For media inquiries relating to editorial content/policy for Nature Genetics, please contact the journal directly:
Orli Bahcall (Nature Genetics, New York)
Tel: +1 212 726 9311; E-mail: [email protected]
About Nature Publishing Group
Nature Publishing Group (NPG) is a division of Macmillan Publishers Ltd, dedicated to serving the academic, professional scientific and medical communities. NPG's flagship title, Nature, was first published in 1869. Other publications include Nature research journals, Nature Reviews, Nature Clinical Practice and a range of prestigious academic journals including society-owned publications. NPG also provides news content through [email protected] and scientific career information through Naturejobs.
NPG is a global company with headquarters in London and offices in New York, San Francisco, Washington DC, Boston, Tokyo, Paris, Munich, Hong Kong, Melbourne, Delhi, Mexico City and Basingstoke. For more information, please go to www.nature.com
